VRCA Verrica Pharmaceuticals Inc

Verrica Pharmaceuticals Inc a clinical-stage medical dermatology company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs.

$13.49  +0.15 (1.09%)
As of 03/05/2021 15:59:11 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Biotechnology
USA
USA
06/15/2018
25,865,542
87,462
$353,840,615
0.00%
SEC Edgar Online
10-Q
10-K
92511W108
US92511W1080
BZ1NTH2

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
0.00
9.03
0.00
-129.43%
0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy